Pharmacy Market BUZZ

Market News, Products, Services, and Trends

2023 Diabetic Drug Changes: What to Expect & How to Manage Them


In 2023, there will be several changes to diabetic drugs that are expected to take place. These changes are aimed at improving the management of diabetes and reducing the risk of complications associated with the condition. We will discuss some of the changes that are taking place in this year and also address how QRx can help your pharmacy manage them.


1. New Insulin Formulations

One of the most significant changes that has taken place in 2023 is the introduction of new insulin formulations. These formulations are designed to provide better glycemic control and reduce the risk of hypoglycemia. Some of the new insulin formulations that are expected to be introduced include ultra-long-acting insulin and concentrated insulin. QRx edits can provide comprehensive edits that can not only review the maximum daily dosage, but also ensure accurate reimbursement.


2. New GLP-1 Receptor Agonists

Another change that is expected to take place in 2023 is the introduction of new GLP-1 receptor agonists. These drugs are designed to stimulate the release of insulin and reduce the production of glucagon, which helps to lower blood sugar levels. Some of the new GLP-1 receptor agonists that are expected to be introduced include once-weekly formulations and combination therapies.  Let QRx review your claim prior to going to the payers to ensure correct payments from the PBMs.


3. New SGLT2 Inhibitors

SGLT2 inhibitors are a class of drugs that are designed to reduce blood sugar levels by blocking the reabsorption of glucose in the kidneys. In 2023, new SGLT2 inhibitors are expected to be introduced that have been shown to reduce the risk of cardiovascular events and kidney disease in people with diabetes.


4. Improved Delivery Systems

In addition to new drug formulations, there are also expected to be improvements in drug delivery systems. For example, new insulin pens and pumps are expected to be introduced that are easier to use and provide more accurate dosing. These improvements are aimed at making it easier for people with diabetes to manage their condition and reduce the risk of complications.

In conclusion, there are several changes to diabetic drugs that are taking place in 2023. These changes are aimed at improving the management of diabetes and reducing the risk of complications associated with the condition.   

QRx can assist pharmacies with all the above-mentioned changes regarding Diabetes with our custom set of Pre and Post edits specifically for Insulin.  Let us help you take the guess work out of claims submission, QRX provides a safety net that ensures accuracy and optimizes reimbursement to help protect your pharmacy’s bottom line. Contact us today for more information. 


Today's Posts
Subscribe